benzinga.com/pressreleases/…

$TXTM Ptr with TruLeaf is a real catalyst! nanotech + kettle tech boosts CBD bioavailability, cuts costs, and delivers Farm Bill-compliant,THC-free FECO. Operational support plus pharma-grade API gives us a major competitive edge.Huge validation & int growth momentum is ahead!

$TXTM. Whats truly exciting is the emphasis on scalability and the blending of traditional assets with newer technologies. It’s the kind of structural diversification that can survive different economic cycles. It continues to be a very interesting long-term play. More to come !

$TXTM. Exactly this. TXTM isn’t trading on reality yet — it’s trading on outdated OTC assumptions. Debt-free, no dilution, audits, transparency, and aligned leadership don’t belong in the bargain bin. Mispricing creates opportunity!

$TXTM context: 2022 was the 1st operating year following a reverse merger into a public shell. That makes the first audit years the most time-intensive due to opening balance validation, legacy cleanup, and control setup. 2022 and 2023 now completed, 2024 should go much quicker!

This is real progress and a clear signal. The Process is well underway, Transparency and accountability through updates. Engaging Deloitte isn’t speculation—it’s infrastructure. Long-term holders recognize what this stage means. $TXTM

Yes. Deloitte involvement is huge. Years of work finally showing through process, compliance, and validation. Leveraging IFRS with Deloitte is alignment, not a restart. No reverse split—just execution. I Appreciate the team building it right. $TXTM

$TXTM. Let’s be clear. A OTC company does NOT bring in a Big 4 firm like Deloitte. It simply doesn’t happen. This sends the biggest signal … to date … IMO … of the scale of Dr J’s plans.

$TXTM Markets are trained to price income statements, not systems. When assets are regenerative, stackable, and verifiable (biologicals, land, water, credits, infrastructure), value accrues before revenue linearity shows up. The gap between asset formation and fin rec is real.

$TXTM. The way this is being set up … is really just plain mind boggling. We are seeing the birth of something great here. It’s definitely not IF. It’s WHEN ! And … it’s not to much longer … IMO.

$TXTM. I’ve been here from the beginning. What a ride ! And the best is still to come. I’m not going anywhere. 🔥❤️

$TXTM. And I’ll add a few. For taking literally $1 salary a year. ( name one other OTC where that happens ). For paying the necessary regulatory costs out of his own pocket! Stock buybacks ….. on and on ! Your one in a million Dr J. 👍

$TXTM FOCUS on “YOUR” GOALS, and DUE DILIGENCE, NOT on the NOISE! 🔥(L)Earn!🔥

$TXTM. The fun and the noise … is just beginning. They go hand and hand. The noise will not stop. If anything it will get worse. As higher benchmarks are made … it will get worse. They will want to shake your faith. And shake your shares. Prepare now mentally.

$TXTM Major catalysts ahead: IFRS audited financials, Deloitte valuation, voluntary EDGAR reporting, and uplisting to a major exchange. Add in RWA tokenization, custodial wallet infrastructure, and proprietary biotech tech, and TXTM is positioning for global scale. ABB!

MULTIPLE U.S. INTELLIGENCE AGENCIES HAVE ASSESSED IN RECENT DAYS THAT THE IRANIAN GOVERNMENT IS NOT CURRENTLY WILLING TO ENGAGE IN SUBSTANTIAL NEGOTIATIONS TO END WAR- NYT

$TXTM. Everyone looking at TXTM should read this. ( from the CEO himself ). Profound Dr J ! 👏

$TXTM #TXTM Uplisting to a major exchange in motion. RWA tokenization of proprietary assets underway. Global expansion locked in. Zero salaries paid since inception. Zero debt. Zero reverse splits. Insiders aggressively buying — zero selling. Their kettle nano-tech is pulling

$TXTM. Shareholders. Excellent video update. A must watch I feel.

$TXTM. These are excellent comments and observations! Thanks.